resiquimod has been researched along with Coronavirus Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bashir, K; Chellappa, MM; Dey, S; Krishnaswamy, N; Kumar, A; Matoo, JJ; Ramakrishnan, S | 1 |
1 other study(ies) available for resiquimod and Coronavirus Infections
| Article | Year |
|---|---|
Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken.
Topics: Adjuvants, Immunologic; Animals; Antibodies, Viral; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Chickens; Coronavirus Infections; Disease Models, Animal; Imidazoles; Immunity; Immunity, Cellular; Immunity, Humoral; Immunity, Mucosal; Immunization; Immunoglobulin A; Infectious bronchitis virus; Leukocytes, Mononuclear; Poultry Diseases; Specific Pathogen-Free Organisms; Transforming Growth Factor beta; Vaccination; Vaccines, Attenuated; Vaccines, Inactivated; Viral Vaccines | 2018 |